Balance Sheet
Liabilities and Shareholders Equity
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Shares Outstanding (2016 - 2024)

KalVista Pharmaceuticals' Shares Outstanding history spans 10 years, with the latest figure at $49.4 million for Q4 2024.

  • For Q4 2024, Shares Outstanding changed N/A year-over-year to $49.4 million; the TTM value through Dec 2024 reached $49.4 million, changed N/A, while the annual FY2024 figure was $42.5 million, N/A changed from the prior year.
  • Shares Outstanding for Q4 2024 was $49.4 million at KalVista Pharmaceuticals, up from $43.3 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $49.4 million in Q4 2024 and bottomed at $17.8 million in Q1 2020.
  • The 4-year median for Shares Outstanding is $34.3 million (2023), against an average of $30.9 million.
  • The largest annual shift saw Shares Outstanding rose 0.36% in 2020 before it grew 25.73% in 2024.
  • A 4-year view of Shares Outstanding shows it stood at $17.9 million in 2020, then increased by 0.59% to $18.0 million in 2021, then surged by 91.01% to $34.4 million in 2023, then surged by 43.61% to $49.4 million in 2024.
  • Per Business Quant, the three most recent readings for KALV's Shares Outstanding are $49.4 million (Q4 2024), $43.3 million (Q4 2024), and $43.1 million (Q3 2024).